+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antidiabetic"

Diabetes Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis by Drug Class, Route of Administration, Distribution Channel - Product Thumbnail Image

Diabetes Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis by Drug Class, Route of Administration, Distribution Channel

  • Report
  • August 2026
  • 160 Pages
  • Global
From
Sulfonylureas Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Sulfonylureas Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • July 2026
  • 160 Pages
  • Global
From
Combination Anti-Diabetes Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Combination Anti-Diabetes Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • July 2026
  • 160 Pages
  • Global
From
Type 2 Diabetes Drugs and Devices Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Distribution Channel - Product Thumbnail Image

Type 2 Diabetes Drugs and Devices Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Distribution Channel

  • Report
  • July 2026
  • 160 Pages
  • Global
From
Meglitinides Market Outlook 2026-2034: Market Share and Growth Analysis - Product Thumbnail Image

Meglitinides Market Outlook 2026-2034: Market Share and Growth Analysis

  • Report
  • April 2026
  • 160 Pages
  • Global
From
Novolog Market Outlook 2026-2034: Market Share and Growth Analysis - Product Thumbnail Image

Novolog Market Outlook 2026-2034: Market Share and Growth Analysis

  • Report
  • April 2026
  • 160 Pages
  • Global
From
Diabetes Devices and Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Diabetes Devices and Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • August 2026
  • 160 Pages
  • Global
From
Global Insulin Delivery Devices Market Outlook, 2031 - Product Thumbnail Image

Global Insulin Delivery Devices Market Outlook, 2031

  • Report
  • January 2026
  • 190 Pages
  • Global
From
Middle East and Africa Diabetes Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

Middle East and Africa Diabetes Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • July 2026
  • 70 Pages
  • Africa, Middle East
From
Europe Diabetes Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

Europe Diabetes Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • July 2026
  • 80 Pages
  • Europe
From
North America Diabetes Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

North America Diabetes Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • July 2026
  • 150 Pages
  • North America
From
Sulfonylurea Hypoglycemic Drug Market in the United States - Product Thumbnail Image

Sulfonylurea Hypoglycemic Drug Market in the United States

  • Report
  • March 2026
  • 150 Pages
  • United States
From
North America Insulin Pen Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Thumbnail Image

North America Insulin Pen Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • November 2025
  • 110 Pages
  • North America
From
Global Glucagon-like Peptide 1 (GLP-1) Market (by Product, Route of Administration, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027) - Product Thumbnail Image

Global Glucagon-like Peptide 1 (GLP-1) Market (by Product, Route of Administration, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)

  • Report
  • November 2023
  • 127 Pages
  • Global
From
Saudi Arabia Diabetes Drug & Insulin Delivery Device Market Opportunity Outlook 2025 - Product Thumbnail Image

Saudi Arabia Diabetes Drug & Insulin Delivery Device Market Opportunity Outlook 2025

  • Report
  • August 2020
  • 250 Pages
  • Saudi Arabia
From
Glucagon-like Peptide 1 (GLP-1) Market: Analysis By Product (Trulicity, Ozempic, Victoza, Rybelsus and Other GLP 1 Products), By Route of Administration (Injectable and Oral Medication), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027 - Product Thumbnail Image

Glucagon-like Peptide 1 (GLP-1) Market: Analysis By Product (Trulicity, Ozempic, Victoza, Rybelsus and Other GLP 1 Products), By Route of Administration (Injectable and Oral Medication), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027

  • Report
  • January 2023
  • 127 Pages
  • Global
From
Latest Development, Product Innovations and Treatments for Diabetes - Product Thumbnail Image

Latest Development, Product Innovations and Treatments for Diabetes

  • Report
  • February 2020
  • 237 Pages
  • Global
From
Netherlands Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis - Product Thumbnail Image

Netherlands Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis

  • Report
  • January 2023
  • 180 Pages
  • Netherlands
From
Saudi Arabia Diabetes Drug Market Trends and Forecast 2026-2034 - Product Thumbnail Image

Saudi Arabia Diabetes Drug Market Trends and Forecast 2026-2034

  • Report
  • August 2026
  • 200 Pages
  • Saudi Arabia
From
Australia Diabetes Market Forecast Report by Type, End User, States and Company Analysis 2026-2034 - Product Thumbnail Image

Australia Diabetes Market Forecast Report by Type, End User, States and Company Analysis 2026-2034

  • Report
  • February 2026
  • 200 Pages
  • Australia
From
Loading Indicator

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides. Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more